Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)
China
· Delayed Price · Currency is CNY 65.98
-2.96 (-4.29%)
At close: Mar 9, 2026
SHE:301033 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Market Capitalization | 4,401 | 2,782 | 2,876 | 2,436 | 4,038 | - | Upgrade
|
| Market Cap Growth | 52.33% | -3.27% | 18.06% | -39.66% | - | - | Upgrade
|
| Enterprise Value | 4,146 | 2,604 | 2,737 | 2,281 | 3,756 | - | Upgrade
|
| Last Close Price | 65.98 | 41.66 | 42.69 | 36.00 | 59.50 | - | Upgrade
|
| PE Ratio | 42.81 | 35.28 | 70.37 | 67.88 | 90.30 | - | Upgrade
|
| Forward PE | - | 40.83 | 46.57 | - | - | - | Upgrade
|
| PS Ratio | 13.07 | 9.99 | 12.46 | 12.48 | 26.26 | - | Upgrade
|
| PB Ratio | 5.86 | 3.98 | 4.52 | 4.04 | 7.01 | - | Upgrade
|
| P/TBV Ratio | 6.46 | 4.37 | 5.08 | 4.42 | 7.80 | - | Upgrade
|
| P/FCF Ratio | 39.53 | 33.43 | 42.55 | - | - | - | Upgrade
|
| P/OCF Ratio | 32.18 | 23.91 | 26.71 | 50.43 | 60.71 | - | Upgrade
|
| EV/Sales Ratio | 12.31 | 9.35 | 11.85 | 11.68 | 24.43 | - | Upgrade
|
| EV/EBITDA Ratio | 31.27 | 24.97 | 40.18 | 58.51 | 113.22 | - | Upgrade
|
| EV/EBIT Ratio | 39.56 | 32.97 | 61.91 | 88.62 | 139.08 | - | Upgrade
|
| EV/FCF Ratio | 37.24 | 31.29 | 40.48 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0 | 0.00 | 0.08 | 0.14 | 0.19 | 0.14 | Upgrade
|
| Debt / EBITDA Ratio | 0.00 | 0.01 | 0.76 | 2.00 | 3.15 | 1.55 | Upgrade
|
| Debt / FCF Ratio | 0.00 | 0.01 | 0.79 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.34 | -0.36 | -0.26 | -0.18 | -0.48 | -0.50 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.95 | -2.39 | -2.44 | -2.83 | -8.30 | -5.55 | Upgrade
|
| Net Debt / FCF Ratio | -2.29 | -2.99 | -2.46 | 1.26 | 3.19 | 6.13 | Upgrade
|
| Asset Turnover | 0.42 | 0.35 | 0.30 | 0.26 | 0.26 | 0.31 | Upgrade
|
| Inventory Turnover | 1.66 | 1.91 | 1.50 | 1.24 | 1.45 | 1.28 | Upgrade
|
| Quick Ratio | 6.00 | 5.80 | 3.51 | 2.49 | 7.25 | 4.03 | Upgrade
|
| Current Ratio | 7.08 | 6.58 | 3.96 | 2.91 | 7.70 | 4.49 | Upgrade
|
| Return on Equity (ROE) | 14.41% | 11.81% | 6.60% | 6.07% | 9.76% | 11.47% | Upgrade
|
| Return on Assets (ROA) | 8.24% | 6.22% | 3.61% | 2.16% | 2.83% | 4.06% | Upgrade
|
| Return on Invested Capital (ROIC) | 18.36% | 14.52% | 7.83% | 5.81% | 9.95% | 13.66% | Upgrade
|
| Return on Capital Employed (ROCE) | 13.10% | 10.50% | 6.10% | 3.90% | 3.90% | 6.50% | Upgrade
|
| Earnings Yield | 2.32% | 2.83% | 1.42% | 1.47% | 1.11% | - | Upgrade
|
| FCF Yield | 2.53% | 2.99% | 2.35% | -3.60% | -2.14% | - | Upgrade
|
| Dividend Yield | 0.87% | 1.44% | 0.94% | 0.56% | 0.17% | - | Upgrade
|
| Payout Ratio | 39.81% | 34.41% | 37.38% | 22.43% | - | - | Upgrade
|
| Buyback Yield / Dilution | -1.32% | 0.33% | 0.80% | -17.43% | -14.83% | 0.28% | Upgrade
|
| Total Shareholder Return | -0.45% | 1.77% | 1.74% | -16.88% | -14.66% | 0.28% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.